Executive record

Paul Reider

Public governance roles and source-backed Claims for this individual.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:paul-reider-chrsVersion: public-0As of: 2026-09-28

Not yet claimed5 published Claims1 sources

Key Claims

Biography

Resigned as Chief Commercial Officer effective April 30, 2025 to pursue other opportunities.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Dates not publishedExecutive title: Chief Commercial Officer · Organization not publishedCHRS executive roster source

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

1 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. CHRS executive roster source

    sec filing · Source published: Date unavailable · Retrieved: May 3, 2026

    Supports 5 claims
    • AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
    • AI governance relevance: AI governance relevance: not identified in the cited filing · Claim reviewed: May 3, 2026
    • Executive company: Executive at Coherus Oncology, Inc. · Claim reviewed: May 3, 2026
    • Executive function: Other Executive (OTHER_EXECUTIVE) · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Chief Commercial Officer · Claim reviewed: May 3, 2026